LAUSR

Sulfiredoxin‐1 is a promising novel prognostic biomarker for hepatocellular carcinoma

Sign Up to like & get
recommendations!
0 Published in 2020 at "Cancer Medicine"

DOI: 10.1002/cam4.3430

Abstract: Identifying novel prognostic biomarkers for hepatocellular carcinoma (HCC) and then, develop an effective individualized treatment strategy remain extremely warranted. The prognostic role of sulfiredoxin‐1(SRXN1), an antioxidant enzyme, remains unknown in HCC. This study aimed to… read more here.

Keywords: hepatocellular carcinoma; hcc; srxn1; novel prognostic ... See more keywords